GeneDx Holdings Corp. (WGS)
Healthcare
Diagnostics & Research
65.10 $
-5.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns GeneDx Holdings Corp. (WGS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 63.8% of the shares are freely tradable; institutional investors hold 114.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
114.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
12.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
63.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
38.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
30Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Corvex Management LP | 10.87 | 3,228,149 | +5.5 | 03/31/2026 |
| Casdin Capital, LLC | 10.13 | 3,007,164 | +0.0 | 03/31/2026 |
| BlackRock Inc | 5.22 | 1,550,708 | -0.6 | 03/31/2026 |
| Westfield Capital Management Company, L.P. | 4.61 | 1,369,108 | +34.5 | 03/31/2026 |
| The Goldman Sachs Group Inc | 4.50 | 1,334,980 | +9.4 | 03/31/2026 |
| ARK Investment Management LLC | 4.46 | 1,324,583 | +119.1 | 03/31/2026 |
| Vanguard Group Inc | 4.01 | 1,189,069 | +1.6 | 12/31/2025 |
| Oracle Investment Management Inc | 2.98 | 884,654 | -0.6 | 12/31/2025 |
| Vanguard Capital Management, LLC | 2.89 | 858,583 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Innovation ETF | 3.59 | 1,064,413 | +2.2 | 05/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.